Cargando…

Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)

OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antim...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hiromichi S., McCracken, Caitlin M., Lininger, Noah, Varley, Cara D., Sikka, Monica K., Evans, Christopher, Villamagna, Angela Holly, Makadia, Jina T., McGregor, Jessina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587378/
https://www.ncbi.nlm.nih.gov/pubmed/37184033
http://dx.doi.org/10.1017/ice.2023.27
_version_ 1785123348778319872
author Park, Hiromichi S.
McCracken, Caitlin M.
Lininger, Noah
Varley, Cara D.
Sikka, Monica K.
Evans, Christopher
Villamagna, Angela Holly
Makadia, Jina T.
McGregor, Jessina C.
author_facet Park, Hiromichi S.
McCracken, Caitlin M.
Lininger, Noah
Varley, Cara D.
Sikka, Monica K.
Evans, Christopher
Villamagna, Angela Holly
Makadia, Jina T.
McGregor, Jessina C.
author_sort Park, Hiromichi S.
collection PubMed
description OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antimicrobial therapy. DESIGN: Single-center retrospective cohort study of symptomatic inpatients admitted for COVID-19 from April 15, 2020, through June 30, 2021. SETTING: Academic quaternary-care referral center in Portland, Oregon. PATIENTS: The study included patients who were 18 years or older with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) PCR test up to 10 days prior to admission. METHODS: Secondary infections were identified based on clinical, radiographic, and microbiologic data. Logistic regression was used to identify risk factors for secondary infection. We also assessed mortality, length of stay, and empiric antibiotics among those with and without secondary infections. RESULTS: We identified 118 patients for inclusion; 31 (26.3%) had either culture-proven or possible secondary infections among hospitalized patients with COVID-19. Mortality was higher among patients with secondary infections (35.5%) compared to those without secondary infection (4.6%). Empiric antibiotic use on admission was high in both the secondary and no secondary infection groups at 71.0% and 48.3%, respectively. CONCLUSIONS: The incidence of secondary bacterial infection was moderate among hospitalized patients with COVID-19. However, a higher proportion of patients received empiric antibiotics regardless of an identifiable secondary infection. Transfer from an outside hospital, baseline immunosuppressant use, and corticosteroid treatment were independent risk factors for secondary infection. Additional studies are needed to validate risk factors and best guide antimicrobial stewardship efforts.
format Online
Article
Text
id pubmed-10587378
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105873782023-10-21 Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) Park, Hiromichi S. McCracken, Caitlin M. Lininger, Noah Varley, Cara D. Sikka, Monica K. Evans, Christopher Villamagna, Angela Holly Makadia, Jina T. McGregor, Jessina C. Infect Control Hosp Epidemiol Original Article OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antimicrobial therapy. DESIGN: Single-center retrospective cohort study of symptomatic inpatients admitted for COVID-19 from April 15, 2020, through June 30, 2021. SETTING: Academic quaternary-care referral center in Portland, Oregon. PATIENTS: The study included patients who were 18 years or older with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) PCR test up to 10 days prior to admission. METHODS: Secondary infections were identified based on clinical, radiographic, and microbiologic data. Logistic regression was used to identify risk factors for secondary infection. We also assessed mortality, length of stay, and empiric antibiotics among those with and without secondary infections. RESULTS: We identified 118 patients for inclusion; 31 (26.3%) had either culture-proven or possible secondary infections among hospitalized patients with COVID-19. Mortality was higher among patients with secondary infections (35.5%) compared to those without secondary infection (4.6%). Empiric antibiotic use on admission was high in both the secondary and no secondary infection groups at 71.0% and 48.3%, respectively. CONCLUSIONS: The incidence of secondary bacterial infection was moderate among hospitalized patients with COVID-19. However, a higher proportion of patients received empiric antibiotics regardless of an identifiable secondary infection. Transfer from an outside hospital, baseline immunosuppressant use, and corticosteroid treatment were independent risk factors for secondary infection. Additional studies are needed to validate risk factors and best guide antimicrobial stewardship efforts. Cambridge University Press 2023-10 2023-05-15 /pmc/articles/PMC10587378/ /pubmed/37184033 http://dx.doi.org/10.1017/ice.2023.27 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Original Article
Park, Hiromichi S.
McCracken, Caitlin M.
Lininger, Noah
Varley, Cara D.
Sikka, Monica K.
Evans, Christopher
Villamagna, Angela Holly
Makadia, Jina T.
McGregor, Jessina C.
Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title_full Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title_fullStr Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title_full_unstemmed Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title_short Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
title_sort incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (covid-19)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587378/
https://www.ncbi.nlm.nih.gov/pubmed/37184033
http://dx.doi.org/10.1017/ice.2023.27
work_keys_str_mv AT parkhiromichis incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT mccrackencaitlinm incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT liningernoah incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT varleycarad incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT sikkamonicak incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT evanschristopher incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT villamagnaangelaholly incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT makadiajinat incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19
AT mcgregorjessinac incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19